Frontiers in Microbiology,
Journal Year:
2020,
Volume and Issue:
11
Published: Aug. 11, 2020
Coronaviruses
are
enveloped,
single
stranded,
positive
sense
RNA
viruses,
which
can
infect
a
variety
of
animals
as
well
human
hosts,
causing
enteric
diseases
and
common
cold,
respectively.
In
humans
the
infection
usually
induces
mild
respiratory
but
sometimes
it
could
be
responsible
for
more
severe
syndrome.
Nowadays,
appearance
new,
highly
pathogenic
lethal
coronavirus
variant,
an
epidemic
in
China
now
pandemic,
represents
global
problem
health.
Unfortunately,
only
limited
approaches
available
to
treat
coronaviruses
infections
vaccine
against
this
new
variant
is
not
yet
available.
Lipid
rafts
small,
dynamic
plasma
membrane
microdomains
enriched
cholesterol,
glycosphingolipids
phospholipids.
They
play
important
role
cellular
functions,
including
cell
signal
transduction
or
regulation
autophagy
and,
because
their
capacity
cluster
several
pathogen
recognition
receptors,
they
represent
port
entry
microbes.
Although
recent
data
highlighted
importance
either
lipid
life
cycle
coronaviruses,
exact
biological
mechanisms
completely
understood
questions
remain
still
unanswered.
review,
we
briefly
describe
characteristic
replication
at
molecular
level.
particular,
will
consider
involvement
replication.
We
also
hint
how
manipulation
may
potential
therapeutic
target
investigated
treatment
infections.
Science,
Journal Year:
2021,
Volume and Issue:
373(6554), P. 541 - 547
Published: June 22, 2021
Repurposing
drugs
as
treatments
for
COVID-19,
the
disease
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
has
drawn
much
attention.
Beginning
with
sigma
receptor
ligands
and
expanding
to
other
from
screening
in
field,
we
became
concerned
that
phospholipidosis
was
a
shared
mechanism
underlying
antiviral
activity
of
many
repurposed
drugs.
For
all
23
cationic
amphiphilic
tested,
including
hydroxychloroquine,
azithromycin,
amiodarone,
four
others
already
clinical
trials,
monotonically
correlated
efficacy.
Conversely,
active
against
same
targets
did
not
induce
were
antiviral.
Phospholipidosis
depends
on
physicochemical
properties
does
reflect
specific
target-based
activities-rather,
it
may
be
considered
toxic
confound
early
drug
discovery.
Early
detection
could
eliminate
these
artifacts,
enabling
focus
molecules
therapeutic
potential.
Scientific Reports,
Journal Year:
2021,
Volume and Issue:
11(1)
Published: March 30, 2021
Abstract
Lipids
are
indispensable
in
the
SARS-CoV-2
infection
process.
The
clinical
significance
of
plasma
lipid
profile
during
COVID-19
has
not
been
rigorously
evaluated.
We
aim
to
ascertain
association
with
evolution.
Observational
cross-sectional
study
including
1411
hospitalized
patients
and
an
available
standard
prior
(n:
1305)
or
hospitalization
297).
usefulness
serum
total,
LDL,
non-HDL
HDL
cholesterol
predict
prognosis
(severe
vs
mild)
was
analysed.
Patients
severe
evolution
had
lower
higher
triglyceride
levels
before
infection.
measured
also
showed
that
a
outcome
associated
triglycerides.
concentrations
were
correlated
ferritin
D-dimer
but
CRP
levels.
presence
atherogenic
dyslipidaemia
strongly
independently
worse
prognosis.
low
high
strong
predictors
course
disease.
should
be
considered
as
sensitive
marker
inflammation
COVID-19.
Journal of Dental Research,
Journal Year:
2020,
Volume and Issue:
100(2), P. 124 - 132
Published: Oct. 22, 2020
The
oral
cavity,
an
essential
part
of
the
upper
aerodigestive
tract,
is
believed
to
play
important
role
in
pathogenicity
and
transmission
SARS-CoV-2.
identification
targeted
antiviral
mouth
rinses
reduce
salivary
viral
load
would
contribute
reducing
COVID-19
pandemic.
While
awaiting
results
significant
clinical
studies,
which
date
do
not
exist,
commercial
availability
leads
us
search
among
them
for
reagents
that
have
specific
properties
with
respect
challenges
facing
this
target
were
examined
7
found
commercially
available
listed
on
ClinicalTrials.gov
website:
povidone-iodine,
chlorhexidine,
hydrogen
peroxide,
cyclodextrin,
Citrox,
cetylpyridinium
chloride,
oils.
Because
SARS-CoV-2
enveloped
virus,
many
outer
lipid
membrane.
Moreover,
some
can
act
capsid
by
denaturing
proteins.
Until
now,
there
has
been
no
scientific
evidence
recommend
anti–SARS-CoV-2
effect
control
cavity.
This
critical
review
indicates
current
knowledge
these
likely
improve
trends
status.
finding
a
strong
sign
encourage
research
quality
protocols
are
already
literature.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: May 1, 2024
Abstract
The
wide
applications
of
liquid
chromatography
-
mass
spectrometry
(LC-MS)
in
untargeted
metabolomics
demand
an
easy-to-use,
comprehensive
computational
workflow
to
support
efficient
and
reproducible
data
analysis.
However,
current
tools
were
primarily
developed
perform
specific
tasks
LC-MS
based
Here
we
introduce
MetaboAnalystR
4.0
as
a
streamlined
pipeline
covering
raw
spectra
processing,
compound
identification,
statistical
analysis,
functional
interpretation.
key
features
includes
auto-optimized
feature
detection
quantification
algorithm
for
LC-MS1
MS2
deconvolution
identification
data-dependent
or
data-independent
acquisition,
more
accurate
interpretation
through
integrated
spectral
annotation.
Comprehensive
validation
studies
using
obtained
from
standards
mixtures,
dilution
series
clinical
samples
have
shown
its
excellent
performance
across
range
common
such
peak
picking,
deconvolution,
with
good
computing
efficiency.
Together
existing
analysis
utilities,
represents
significant
step
toward
unified,
end-to-end
global
the
open-source
R
environment.
Signal Transduction and Targeted Therapy,
Journal Year:
2020,
Volume and Issue:
5(1)
Published: Sept. 3, 2020
Sterol
regulatory
element
binding
protein-2
(SREBP-2)
is
activated
by
cytokines
or
pathogen,
such
as
virus
bacteria,
but
its
association
with
diminished
cholesterol
levels
in
COVID-19
patients
unknown.
Here,
we
evaluated
SREBP-2
activation
peripheral
blood
mononuclear
cells
of
and
verified
the
function
COVID-19.
Intriguingly,
report
first
observation
C-terminal
fragment
patients'
propose
an
indicator
for
determining
severity.
We
confirmed
that
SREBP-2-induced
biosynthesis
was
suppressed
Sestrin-1
PCSK9
expression,
while
inflammatory
responses
upregulated
ICU
patients.
Using
infectious
disease
mouse
model,
inhibitors
NF-κB
cytokine
storms
caused
viral
infection
prevented
pulmonary
damages.
These
results
collectively
suggest
can
serve
severity
diagnosis
therapeutic
target
preventing
storm
lung
damage
severe
Biotechnology Journal,
Journal Year:
2020,
Volume and Issue:
15(6)
Published: April 18, 2020
The
recent
outbreak
of
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
previously
known
by
provisional
name
2019
novel
(2019-nCoV),
in
city
Wuhan
China's
Hubei
province
2019–2020
has
been
causing
significant
numbers
mortality
and
morbility
humans
with
infection
diseases
(COVID-19)
fever,
illness,
pneumonia.[1-3]
Till
April
8,
2020,
there
have
over
1
431
973
confirmed
cases
globally,
leading
to
at
least
82
085
deaths.
These
SARS-CoV-2
isolates
belong
Betacoronavirus
genus
Coronaviradae
family
which
is
an
enveloped
single-stranded
RNA
virus
containing
a
30
kb
genome
14
open
reading
frames
including
four
major
viral
structure
proteins:
spike
(S),
membrane
(M),
envelope
(E),
nucleocapsid
(N)
proteins.[4-7]
S
gene
sequences
93.1%
nucleotide
sequence
identity
Rhinolophus
affinis
bat
RaTG13,
but
only
less
than
75%
(SARS-CoV).
compared
SARS-CoV
three
additional
short
insertions
N-terminal
domain,
out
five
key
residues
changes
receptor-binding
motif
protein
receptor
binding
domain
(RBD).[6,
7]
Although
both
share
same
human
cellular
receptor-angiotensin
converting
enzyme
II,
appears
be
more
readily
transmitted
from
human.[1,
9]
target
for
COVID-19
vaccine
development,
mainly
based
on
elicitation
neutralizing
antibodies
as
immune
correlates
protection.
current
status
development
includes,
i)
phase
I
candidates,
ii)
11
preclinical
iii)
26
research-stage
candidates
(Table
1;
[https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker?feed=Regulatory-Focus?utm_source=Facebook&utm_medium=social&utm_campaign=Regulatory-Focus]).
Most
these
are
antigen
either
inactivated
vaccines,
subunit
vectored
nucleic
acid-based
DNA
or
mRNA
vaccines.
Among
Coalition
Epidemic
Preparedness
Innovations
(CEPI)
provided
funding
develop
vaccines
using
following
platform
technology:
a)
Curevac
Inc.
(mRNA),
b)
Inovio
Pharmaceuticals
(DNA),
c)
Moderna,
d)
University
Queensland
(molecular
clam),
e)
Novavax
(nanoparticles),
f)
Oxford
(adenovirus
vector),
g)
Hong
Kong
(live-attenuated
influenza
virus),
h)
Institute
Pasteur
(measles
vector)
accelerate
enable
equitable
access
people
during
outbreaks
[https://cepi.net/covid-19/].
Phase
NCT04283461
ChiCTR2000030906
NCT04336410
Re-purposed
SARS
vaccine;
S1
RBD
To
date,
many
previous
studies
SARS-CoV,
Middle
East
syndrome-related
(MERS-CoV),
other
revealed
several
safety
concerns
associated
use
S-based
inflammatory
immunopathological
effects
such
pulmonary
eosinophilic
infiltration
antibody-dependent
disease
enhancement
(ADE)
subsequent
challenge
vaccinated
animals.[10-21]
anti-S
ADE
may
facilitate
uptake
macrophage
expressing
FcR,
stimulation
production
proinflammatory
cytokines
(IL-6,
IL-8,
MCP1)
loss
tissue-repaired
cytokine
(TGFβ).[22]
Moreover,
Th2-associated
immunopathology
documented
syncytial
after
challenge[23-25]
MERS-CoV
challenge.[20]
Thus,
potentially
harmful
responses
against
any
coronaviruses
should
carefully
assessed
trials.[26]
It
proposed
that
epitope-rich
region,
instead
entire
full-length
alternative
development.[27]
Whether
SARS-CoV-2,
selection
Th1-skewed
adjuvants
rather
alum
adjuvant,
can
avoid
inflammatory,
immunopathological,
effects,
requires
further
animal
models
trials.
findings
particularly
important
developing
safe
effective
vaccine.
Suh-Chin
Wu
This
work
was
supported
Ministry
Science
Technology,
Taiwan
(MOST108-2321-B-007-001,
MOST108-2321-B-002-006),
National
Tsing
Hua
(109R2807E1).
author
declares
no
conflict
interest.
Cell Reports,
Journal Year:
2021,
Volume and Issue:
36(5), P. 109479 - 109479
Published: July 20, 2021
Coronaviruses
rely
on
host
membranes
for
entry,
establishment
of
replication
centers,
and
egress.
Compounds
targeting
cellular
membrane
biology
lipid
biosynthetic
pathways
have
previously
shown
promise
as
antivirals
are
actively
being
pursued
treatments
other
conditions.
Here,
we
test
small
molecule
inhibitors
that
target
the
PI3
kinase
VPS34
or
fatty
acid
metabolism
anti-severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
activity.
Our
studies
determine
compounds
potent
SARS-CoV-2
inhibitors.
Mechanistic
with
multiple
steps
up-
downstream
synthase
(FASN)
identify
importance
triacylglycerol
production
protein
palmitoylation
requirements
efficient
viral
RNA
synthesis
infectious
virus
production.
Further,
FASN
knockout
results
in
significantly
impaired
can
be
rescued
supplementation.
Together,
these
clarify
roles
promising
avenues
development
countermeasures
against
SARS-CoV-2.